{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:46Z","timestamp":1791489646420,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":229,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101385","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:32:46Z","timestamp":1787373166000},"page":"101385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Baseline visceral adipose tissue radiodensity as biomarker of survival in advanced NSCLC treated with first-line single-agent immunotherapy"],"prefix":"10.1016","volume":"49","author":[{"given":"Francesca","family":"Piazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Gatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Carola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Baggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ammoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Signoroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ravanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6922-1934","authenticated-orcid":false,"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ctarc.2026.101385_bib0001","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamaoncol.2024.1120","article-title":"Body composition in advanced non-small cell lung cancer treated with immunotherapy","volume":"10","author":"Chaunzwa","year":"2024","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101385_bib0002","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.juro.2018.01.069","article-title":"Subcutaneous fat distribution is a prognostic biomarker for men with castration resistant prostate cancer","volume":"200","author":"Lee","year":"2018","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101385_bib0003","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101385_bib0004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clnu.2021.11.012","article-title":"Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer\u2014 a multicenter population-based cohort study","volume":"41","author":"Maurits","year":"2022","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101385_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/jitc-2020-001117","article-title":"Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study","volume":"8","author":"Rutkowski","year":"2020","journal-title":"J. ImmunOther Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101385_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0527-y","article-title":"A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable","volume":"7","author":"Cortellini","year":"2019","journal-title":"J. ImmunOther Cancer"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101385_bib0007","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1177\/0148607114550189","article-title":"Heymsfield SB. Lean tissue imaging: a new era for nutritional assessment and intervention","volume":"38","author":"Prado","year":"2014","journal-title":"J. Parenter Enteral Nutr."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101385_bib0008","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13244-023-01532-4","article-title":"Prognostic utility of body composition parameters based on computed tomography analysis of advanced non \u2011 small cell lung cancer treated with immune checkpoint inhibitors","volume":"14","author":"Park","year":"2023","journal-title":"Insights. ImAging"},{"key":"10.1016\/j.ctarc.2026.101385_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103068","article-title":"Radiomics and \u201c radi- \u2026 omics \u201d in cancer immunotherapy : a guide for clinicians","volume":"154","author":"Porcu","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101385_bib0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.numecd.2015.12.002","article-title":"Abdominal fat radiodensity, quantity and cardiometabolic risk: the multi-ethnic study of atherosclerosis","volume":"26","author":"Shah","year":"2016","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ctarc.2026.101385_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1044737","article-title":"Drastic transformation of visceral adipose tissue and peripheral CD4 T cells in obesity","volume":"13","author":"Shirakawa","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101385_bib0012","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.230024","article-title":"Robust segmentation of 104 anatomic structures in CT images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiol. Artif. Intell."},{"issue":"21","key":"10.1016\/j.ctarc.2026.101385_bib0013","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"Van Griethuysen","year":"2017","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101385_bib0014","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40519-018-0489-y","article-title":"The obesity paradox in cancer: clinical insights and perspectives","volume":"23","author":"Trestini","year":"2018","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.ctarc.2026.101385_bib0015","article-title":"High visceral adipose tissue density correlates with unfavorable outcomes in patients with intermediate-stage hepatocellular carcinoma undergoing transarterial chemoembolization","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101385_bib0016","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/cancers12020356","article-title":"Visceral adipose tissue radiodensity is linked to prognosis in hepatocellular carcinoma patients treated with selective internal radiation therapy","volume":"12","author":"Ebadi","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101385_bib0017","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/ajcn\/nqab285","article-title":"Abdominal adipose tissue radiodensity is associated with survival after colorectal cancer","volume":"114","author":"Feliciano","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ctarc.2026.101385_bib0018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clnu.2025.04.019","article-title":"Automated three-dimensional body composition analysis identifies visceral adipose tissue radiodensity as a predictor of mortality and recurrence in colorectal cancer","volume":"51","author":"Mai","year":"2025","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101385_bib0019","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12885-019-5319-8","article-title":"Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials","volume":"19","author":"Charette","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101385_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1210\/jc.2013-4296","article-title":"Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality","volume":"100","author":"Rosenquist","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ctarc.2026.101385_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.576314","article-title":"Obesity, sarcopenia, and outcomes in non\u2011small cell lung cancer patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors","volume":"10","author":"Khaddour","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101385_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111141","article-title":"Adipose tissue radiodensity: a new prognostic biomarker in people with multiple myeloma","volume":"86","author":"Da Cunha","year":"2021","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101385_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14740\/wjon1225","article-title":"Sarcopenia and visceral adiposity did not affect efficacy of immune-checkpoint inhibitor monotherapy for pretreated patients with advanced non-small cell lung cancer","volume":"11","author":"Minami","year":"2020","journal-title":"World J. Oncol."},{"key":"10.1016\/j.ctarc.2026.101385_bib0024","article-title":"Prognostic impact of sarcopenia on clinical outcomes in malignancies treated with immune checkpoint inhibitors: a systematic review and meta analysis","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101385_bib0025","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/1750743X.2025.2525743","article-title":"Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors","volume":"17","author":"Sahin","year":"2025","journal-title":"Immunotherapy"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:42:33Z","timestamp":1791488553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"alternative-id":["S2468294226002960"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101385","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline visceral adipose tissue radiodensity as biomarker of survival in advanced NSCLC treated with first-line single-agent immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101385"}}